PD 0332991 HCl (Palbociclib)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | PD 0332991 HCl is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. | ||
---|---|---|---|
Targets |
|
Catalog Num | A10701 |
---|---|
Formula | C24H29N7O2.HCl |
Molecular Weight | 484 |
CAS Number | 827022-32-2 |
SMILES | CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C.Cl |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | Warmed: 3 mg/mL (6.19 mM) | |
Water | 30 mg/mL (61.98 mM) | ||
Ethanol | Insoluble | ||
In vivo | Saline | 5 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.66 mL | 103.31 mL | 206.61 mL |
0.5 mM | 4.13 mL | 20.66 mL | 41.32 mL |
1 mM | 2.07 mL | 10.33 mL | 20.66 mL |
5 mM | 0.41 mL | 2.07 mL | 4.13 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2